{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:49:10Z","timestamp":1793213350563,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MFE-194064"],"award-info":[{"award-number":["MFE-194064"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RF1AG069228 ; 5R01AG070257"],"award-info":[{"award-number":["1RF1AG069228 ; 5R01AG070257"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32797-y","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:07:30Z","timestamp":1768406850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protection of multiple aspects of Alzheimer\u2019s disease pathology using dietary supplementation with taurine"],"prefix":"10.1038","volume":"16","author":[{"given":"Christina M.","family":"Tognoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshree","family":"Ghosh Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Melis","family":"Suar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpaslan","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"32797_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2010.03.011","volume":"59","author":"JK Choi","year":"2010","unstructured":"Choi, J. K., Carreras, I., Dedeoglu, A. & Jenkins, B. G. Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in alzheimer\u2019s disease mouse models. Neuropharmacology 59, 353\u2013357 (2010).","journal-title":"Neuropharmacology"},{"key":"32797_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/B978-0-12-394816-8.00006-4","volume":"64","author":"K Ma","year":"2012","unstructured":"Ma, K., Thomason, L. A. M. & McLaurin, J. scyllo-Inositol, preclinical, and clinical data for alzheimer\u2019s disease. Adv. Pharmacol. 64, 177\u2013212 (2012).","journal-title":"Adv. Pharmacol."},{"key":"32797_CR3","first-page":"e12295","volume":"8","author":"J Cummings","year":"2022","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2022. Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions. 8, e12295 (2022).","journal-title":"Alzheimer\u2019s Dementia: Translational Res. Clin. Interventions"},{"key":"32797_CR4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","volume":"87","author":"CK Kim","year":"2022","unstructured":"Kim, C. K. et al. Alzheimer\u2019s disease: key insights from two decades of clinical trial failures. J. Alzheimer\u2019s Disease. 87, 83\u2013100 (2022).","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"32797_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/547153a","volume":"547","author":"E McDade","year":"2017","unstructured":"McDade, E. & Bateman, R. J. Stop alzheimer\u2019s before it starts. Nature 547, 153\u2013155 (2017).","journal-title":"Nature"},{"key":"32797_CR6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2016.07.152","volume":"13","author":"V Bellou","year":"2017","unstructured":"Bellou, V. et al. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimer\u2019s Dement. 13, 406\u2013418 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"32797_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-023-02772-3","volume":"21","author":"OM Shannon","year":"2023","unstructured":"Shannon, O. M. et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK biobank prospective cohort study. BMC Med. 21, 81 (2023).","journal-title":"BMC Med."},{"key":"32797_CR8","doi-asserted-by":"crossref","unstructured":"Zhang, C., Wang, Y., Wang, D., Zhang, J. & Zhang, F. N. S. A. I. D. Exposure and risk of alzheimer\u2019s disease: an updated Meta-Analysis from cohort studies. Front. Aging Neurosci. 10, (2018).","DOI":"10.3389\/fnagi.2018.00083"},{"key":"32797_CR9","doi-asserted-by":"crossref","unstructured":"Sohail, R. et al. Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review. Cureus 15, (2023).","DOI":"10.7759\/cureus.37080"},{"key":"32797_CR10","doi-asserted-by":"publisher","unstructured":"Louzata, P. R., Paula Lima, A. C., Mendonca-Silva, D. L., Noel, F., De Mello, F. G., Ferreira, S. T. Taurine prevents the neurotoxicity of \u03b2-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer\u2019s disease and other neurological disorders. FASEB J. 18, 511\u2013518. https:\/\/doi.org\/10.1096\/fj.03-0739com (2004).","DOI":"10.1096\/fj.03-0739com"},{"key":"32797_CR11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/nu14061292","volume":"14","author":"Z Rafiee","year":"2022","unstructured":"Rafiee, Z., Garc\u00eda-Serrano, A. M. & Duarte, J. M. N. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes. Nutrients 14, 1292 (2022).","journal-title":"Nutrients"},{"key":"32797_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2012.09.003","volume":"50","author":"AC Lo","year":"2013","unstructured":"Lo, A. C., Callaerts-Vegh, Z., Nunes, A. F., Rodrigues, C. M. P. & D\u2019Hooge, R. Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP\/PS1 mice. Neurobiol. Dis. 50, 21\u201329 (2013).","journal-title":"Neurobiol. Dis."},{"key":"32797_CR13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s11064-005-8986-6","volume":"30","author":"J Albrecht","year":"2005","unstructured":"Albrecht, J. & Schousboe, A. Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem Res. 30, 1615\u20131621 (2005).","journal-title":"Neurochem Res."},{"key":"32797_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2012.2432","volume":"32","author":"M Sun","year":"2015","unstructured":"Sun, M., Zhao, Y., Gu, Y. & Zhang, Y. Protective effects of taurine against closed head injury in rats. J. Neurotrauma. 32, 66\u201374 (2015).","journal-title":"J. Neurotrauma"},{"key":"32797_CR15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/brainsci3020877","volume":"3","author":"J Menzie","year":"2013","unstructured":"Menzie, J., Prentice, H. & Wu, J. Y. Neuroprotective mechanisms of taurine against ischemic stroke. Brain Sci. 3, 877\u2013907 (2013).","journal-title":"Brain Sci."},{"key":"32797_CR16","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00726-016-2244-x","volume":"48","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Protective effects of taurine in traumatic brain injury via mitochondria and cerebral blood flow. Amino Acids. 48, 2169\u20132177 (2016).","journal-title":"Amino Acids"},{"key":"32797_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","volume":"90","author":"Y Ohsawa","year":"2019","unstructured":"Ohsawa, Y. et al. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J. Neurol. Neurosurg. Psychiatry. 90, 529\u2013536 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"32797_CR18","doi-asserted-by":"crossref","unstructured":"Aamer, H. et al. Exploring taurine\u2019s potential in alzheimer\u2019s treatment: A comprehensive review. Cureus 16, (2024).","DOI":"10.7759\/cureus.60997"},{"key":"32797_CR19","doi-asserted-by":"crossref","first-page":"15551","DOI":"10.1038\/s41598-020-72755-4","volume":"10","author":"SJ Oh","year":"2020","unstructured":"Oh, S. J. et al. Evaluation of the neuroprotective effect of taurine in alzheimer\u2019s disease using functional molecular imaging. Sci. Rep. 10, 15551 (2020).","journal-title":"Sci. Rep."},{"key":"32797_CR20","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1038\/srep07467","volume":"4","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y. et al. Taurine in drinking water recovers learning and memory in the adult APP\/PS1 mouse model of alzheimer\u2019s disease. Sci. Rep. 4, 7467 (2014).","journal-title":"Sci. Rep."},{"key":"32797_CR21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/1028415X.2022.2131062","volume":"26","author":"AM Garcia-Serrano","year":"2023","unstructured":"Garcia-Serrano, A. M., Vieira, J. P. P., Fleischhart, V. & Duarte, J. M. N. Taurine and N-acetylcysteine treatments prevent memory impairment and metabolite profile alterations in the hippocampus of high-fat diet-fed female mice. Nutr. Neurosci. 26, 1090\u20131102 (2023).","journal-title":"Nutr. Neurosci."},{"key":"32797_CR22","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.3390\/ijms241914769","volume":"24","author":"M Ambeskovic","year":"2023","unstructured":"Ambeskovic, M. et al. Metabolomic signatures of alzheimer\u2019s disease indicate brain Region-Specific neurodegenerative progression. Int. J. Mol. Sci. 24, 14769 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"32797_CR23","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.3390\/ijms24054960","volume":"24","author":"C Yin","year":"2023","unstructured":"Yin, C., Harms, A. C., Hankemeier, T., Kindt, A. & de Lange, E. C. M. Status of metabolomic measurement for insights in alzheimer\u2019s disease Progression\u2014What is missing? Int. J. Mol. Sci. 24, 4960 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"32797_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.expneurol.2009.07.032","volume":"223","author":"JK Choi","year":"2010","unstructured":"Choi, J. K. et al. Anti-inflammatory treatment in AD mice protects against neuronal pathology. Exp. Neurol. 223, 377\u2013384 (2010).","journal-title":"Exp. Neurol."},{"key":"32797_CR25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiology.195.1.7892497","volume":"195","author":"TK Shonk","year":"1995","unstructured":"Shonk, T. K. et al. Probable alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195, 65\u201372 (1995).","journal-title":"Radiology"},{"key":"32797_CR26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2004.02.079","volume":"1012","author":"A Dedeoglu","year":"2004","unstructured":"Dedeoglu, A., Choi, J. K., Cormier, K., Kowall, N. W. & Jenkins, B. G. Magnetic resonance spectroscopic analysis of alzheimer\u2019s disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res. 1012, 60\u201365 (2004).","journal-title":"Brain Res."},{"issue":"Suppl 3","key":"32797_CR27","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3233\/JAD-2012-112072","volume":"31","author":"V Mlyn\u00e1rik","year":"2012","unstructured":"Mlyn\u00e1rik, V. et al. Proton and phosphorus magnetic resonance spectroscopy of a mouse model of alzheimer\u2019s disease. J. Alzheimers Dis. 31 (Suppl 3), S87\u201399 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"32797_CR28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2013.10.001","volume":"250","author":"N Aytan","year":"2013","unstructured":"Aytan, N. et al. Combination therapy in a Transgenic model of alzheimer\u2019s disease. Exp. Neurol. 250, 228\u2013238 (2013).","journal-title":"Exp. Neurol."},{"key":"32797_CR29","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/nbm.1132","volume":"20","author":"HR Griffith","year":"2007","unstructured":"Griffith, H. R. et al. Elevated brain scyllo-inositol concentrations in patients with alzheimer\u2019s disease. NMR Biomed. 20, 709\u2013716 (2007).","journal-title":"NMR Biomed."},{"key":"32797_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2008.03.009","volume":"31","author":"D Tripathy","year":"2010","unstructured":"Tripathy, D., Thirumangalakudi, L. & Grammas, P. RANTES upregulation in the alzheimer\u2019s disease brain: A possible neuroprotective role. Neurobiol. Aging. 31, 8\u201316 (2010).","journal-title":"Neurobiol. Aging"},{"key":"32797_CR31","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","volume":"8","author":"WJ Lee","year":"2018","unstructured":"Lee, W. J. et al. Plasma MCP-1 and cognitive decline in patients with alzheimer\u2019s disease and mild cognitive impairment: A Two-year Follow-up study. Sci. Rep. 8, 1280 (2018).","journal-title":"Sci. Rep."},{"key":"32797_CR32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury, J. et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432\u2013438 (2007).","journal-title":"Nat. Med."},{"key":"32797_CR33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.neurobiolaging.2012.08.009","volume":"34","author":"T Kiyota","year":"2013","unstructured":"Kiyota, T. et al. CCL2 affects \u03b2-amyloidosis and progressive neurocognitive dysfunction in a mouse model of alzheimer\u2019s disease. Neurobiol. Aging. 34, 1060\u20131068 (2013).","journal-title":"Neurobiol. Aging"},{"key":"32797_CR34","first-page":"e12158","volume":"7","author":"H Potter","year":"2021","unstructured":"Potter, H. et al. Safety and efficacy of sargramostim (GM-CSF) in the treatment of alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Transl. Res. Clin. Interventions. 7, e12158 (2021).","journal-title":"Alzheimer\u2019s Dementia: Transl. Res. Clin. Intervent."},{"key":"32797_CR35","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.4049\/jimmunol.0903382","volume":"184","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty, P. et al. IFN-\u03b3 promotes complement expression and attenuates amyloid plaque deposition in amyloid \u03b2 precursor protein Transgenic mice. J. Immunol. 184, 5333\u20135343 (2010).","journal-title":"J. Immunol."},{"key":"32797_CR36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty, P. et al. Massive gliosis induced by interleukin-6 suppresses A\u03b2 deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 24, 548\u2013559 (2010).","journal-title":"FASEB J."},{"key":"32797_CR37","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/biom10071017","volume":"10","author":"C Porro","year":"2020","unstructured":"Porro, C., Cianciulli, A. & Panaro, M. A. The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules 10, 1017 (2020).","journal-title":"Biomolecules"},{"key":"32797_CR38","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang, W. Y., Tan, M. S., Yu, J. T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in alzheimer\u2019s disease. Ann. Transl Med. 3, 136 (2015).","journal-title":"Ann. Transl Med."},{"key":"32797_CR39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","volume":"76","author":"R Taipa","year":"2019","unstructured":"Taipa, R. et al. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol. Aging. 76, 125\u2013132 (2019).","journal-title":"Neurobiol. Aging"},{"key":"32797_CR40","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli, R. C. et al. Microglia States and nomenclature: A field at its crossroads. Neuron 110, 3458\u20133483 (2022).","journal-title":"Neuron"},{"key":"32797_CR41","doi-asserted-by":"crossref","first-page":"18561","DOI":"10.1038\/s41598-020-75517-4","volume":"10","author":"A Kantarci","year":"2020","unstructured":"Kantarci, A. et al. Microglial response to experimental periodontitis in a murine model of alzheimer\u2019s disease. Sci. Rep. 10, 18561 (2020).","journal-title":"Sci. Rep."},{"key":"32797_CR42","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1038\/s41598-021-85502-0","volume":"11","author":"YS Lin","year":"2021","unstructured":"Lin, Y. S. et al. Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice. Sci. Rep. 11, 6013 (2021).","journal-title":"Sci. Rep."},{"key":"32797_CR43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1155\/2006\/276239","volume":"22","author":"Z Xiang","year":"2006","unstructured":"Xiang, Z., Haroutunian, V., Ho, L., Purohit, D. & Pasinetti, G. M. Microglia activation in the brain as inflammatory biomarker of alzheimer\u2019s disease neuropathology and clinical dementia. Dis. Markers. 22, 95\u2013102 (2006).","journal-title":"Dis. Markers"},{"key":"32797_CR44","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-Associated microglia: A universal immune sensor of neurodegeneration. Cell 173, 1073\u20131081 (2018).","journal-title":"Cell"},{"key":"32797_CR45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-024-02828-5","volume":"148","author":"JM Phillips","year":"2024","unstructured":"Phillips, J. M. et al. Pathologic and clinical correlates of region-specific brain GFAP in alzheimer\u2019s disease. Acta Neuropathol. 148, 69 (2024).","journal-title":"Acta Neuropathol."},{"key":"32797_CR46","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.3390\/ijms25179475","volume":"25","author":"M Ianni","year":"2024","unstructured":"Ianni, M. et al. Spatiotemporal dysregulation of Neuron\u2013Glia related genes and Pro-\/Anti-Inflammatory MiRNAs in the 5xFAD mouse model of alzheimer\u2019s disease. Int. J. Mol. Sci. 25, 9475 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"32797_CR47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang, Z. & Wang, K. K. W. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 38, 364\u2013374 (2015).","journal-title":"Trends Neurosci."},{"key":"32797_CR48","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","volume":"26","author":"S Brahmachari","year":"2006","unstructured":"Brahmachari, S., Fung, Y. K. & Pahan, K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci. 26, 4930\u20134939 (2006).","journal-title":"J. Neurosci."},{"key":"32797_CR49","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1073\/pnas.242746599","volume":"100","author":"J Redwine","year":"2003","unstructured":"Redwine, J. et al. (ed, M.) Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Proc. Natl. Acad. Sci. 1001381\u20131386 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"32797_CR50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jmb.2006.09.046","volume":"364","author":"Y Yan","year":"2006","unstructured":"Yan, Y. & Wang, C. A\u03b242 is more rigid than A\u03b240 at the C terminus: implications for A\u03b2 aggregation and toxicity. J. Mol. Biol. 364, 853\u2013862 (2006).","journal-title":"J. Mol. Biol."},{"key":"32797_CR51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2014.04.019","volume":"447","author":"Q Sun","year":"2014","unstructured":"Sun, Q. et al. Taurine attenuates amyloid \u03b2 1\u201342-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells. Biochem. Biophys. Res. Commun. 447, 485\u2013489 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"32797_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-94-024-1079-2_21","volume-title":"Taurine 10","author":"H Jang","year":"2017","unstructured":"Jang, H. et al. Taurine directly binds to oligomeric Amyloid-\u03b2 and recovers cognitive deficits in alzheimer model mice. in Taurine 10 (eds (eds Lee, D. H., Schaffer, S. W., Park, E. & Kim, H. W.) 233\u2013241 (Springer Netherlands, Dordrecht, https:\/\/doi.org\/10.1007\/978-94-024-1079-2_21 . (2017)."},{"key":"32797_CR53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnana.2018.00083","volume":"12","author":"D Keller","year":"2018","unstructured":"Keller, D., Er\u00f6, C. & Markram, H. Cell densities in the mouse brain: A systematic review. Front. Neuroanat. 12, 83 (2018).","journal-title":"Front. Neuroanat."},{"key":"32797_CR54","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archneurol.2011.167","volume":"68","author":"MR Sabuncu","year":"2011","unstructured":"Sabuncu, M. R. et al. The dynamics of cortical and hippocampal atrophy in alzheimer disease. Arch. Neurol. 68, 1040\u20131048 (2011).","journal-title":"Arch. Neurol."},{"key":"32797_CR55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.WCB.0000056062.25434.4D","volume":"23","author":"C Zwingmann","year":"2003","unstructured":"Zwingmann, C., Leibfritz, D. & Hazell, A. S. Energy metabolism in astrocytes and neurons treated with manganese: relation among Cell-Specific energy Failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-Spectroscopic analysis. J. Cereb. Blood Flow. Metab. 23, 756\u2013771 (2003).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"32797_CR56","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1523\/JNEUROSCI.13-03-00981.1993","volume":"13","author":"J Urenjak","year":"1993","unstructured":"Urenjak, J., Williams, S. R., Gadian, D. G. & Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981\u2013989 (1993).","journal-title":"J. Neurosci."},{"key":"32797_CR57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson, L. J., Perry, V. H., Dri, P. & Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151\u2013170 (1990).","journal-title":"Neuroscience"},{"key":"32797_CR58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nbd.2018.05.023","volume":"117","author":"JP Doll\u00e9","year":"2018","unstructured":"Doll\u00e9, J. P. et al. Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro. Neurobiol. Dis. 117, 161\u2013169 (2018).","journal-title":"Neurobiol. Dis."},{"key":"32797_CR59","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/jcbfm.2010.199","volume":"31","author":"L Hertz","year":"2011","unstructured":"Hertz, L. Brain glutamine synthesis requires neuronal aspartate: A commentary. J. Cereb. Blood Flow. Metab. 31, 384\u2013387 (2011).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"32797_CR60","doi-asserted-by":"crossref","first-page":"105198","DOI":"10.1016\/j.nbd.2020.105198","volume":"148","author":"JV Andersen","year":"2021","unstructured":"Andersen, J. V. et al. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of alzheimer\u2019s disease. Neurobiol. Dis. 148, 105198 (2021).","journal-title":"Neurobiol. Dis."},{"key":"32797_CR61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.neurobiolaging.2004.02.016","volume":"25","author":"A Walter","year":"2004","unstructured":"Walter, A. et al. Glycerophosphocholine is elevated in cerebrospinal fluid of alzheimer patients. Neurobiol. Aging. 25, 1299\u20131303 (2004).","journal-title":"Neurobiol. Aging"},{"key":"32797_CR62","doi-asserted-by":"crossref","unstructured":"Nitsch, R. M. et al. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. 89, 1671\u20131675 (1992).","DOI":"10.1073\/pnas.89.5.1671"},{"key":"32797_CR63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0006-8993(90)90030-F","volume":"536","author":"JK Blusztajn","year":"1990","unstructured":"Blusztajn, J. K., Gonzalez-Coviella, I. L., Logue, M., Growdon, J. H. & Wurtman, R. J. Levels of phospholipid catabolic intermediates, Glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of alzheimer\u2019s disease but not of down\u2019s syndrome patients. Brain Res. 536, 240\u2013244 (1990).","journal-title":"Brain Res."},{"key":"32797_CR64","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/nu13062091","volume":"13","author":"Y Tamura","year":"2021","unstructured":"Tamura, Y., Takata, K., Matsubara, K. & Kataoka, Y. Alpha-Glycerylphosphorylcholine increases motivation in healthy volunteers: A Single-Blind, Randomized, Placebo-Controlled human study. Nutrients 13, 2091 (2021).","journal-title":"Nutrients"},{"key":"32797_CR65","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/bbb\/zbad135","volume":"87","author":"M Umino","year":"2023","unstructured":"Umino, M., Okuda, M., Ohkubo, T., Fujii, T. & Matsubara, K. Long-term intake of \u03b1-glycerophosphocholine (GPC) suppresses microglial inflammation and blood-brain barrier (BBB) disruption and promotes neurogenesis in senescence-accelerated mice prone 8 (SAMP8). Biosci. Biotechnol. Biochem. 87, 1537\u20131542 (2023).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"32797_CR66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-020-0582-0","volume":"12","author":"AP Mecca","year":"2020","unstructured":"Mecca, A. P. et al. PET imaging of mGluR5 in alzheimer\u2019s disease. Alz Res. Therapy. 12, 15 (2020).","journal-title":"Alz Res. Therapy"},{"key":"32797_CR67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(98)00451-0","volume":"250","author":"A D\u2019Aniello","year":"1998","unstructured":"D\u2019Aniello, A., Lee, J. M., Petrucelli, L. & Di Fiore M. M. Regional decreases of free d-aspartate levels in alzheimer\u2019s disease. Neurosci. Lett. 250, 131\u2013134 (1998).","journal-title":"Neurosci. Lett."},{"key":"32797_CR68","doi-asserted-by":"crossref","first-page":"e14137","DOI":"10.1111\/acel.14137","volume":"23","author":"S Lee","year":"2024","unstructured":"Lee, S. et al. Multi-proteomic analyses of 5xFAD mice reveal new molecular signatures of early-stage alzheimer\u2019s disease. Aging Cell. 23, e14137 (2024).","journal-title":"Aging Cell."},{"key":"32797_CR69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","volume":"12","author":"JL Jankowsky","year":"2017","unstructured":"Jankowsky, J. L. & Zheng, H. Practical considerations for choosing a mouse model of alzheimer\u2019s disease. Mol. Neurodegeneration. 12, 89 (2017).","journal-title":"Mol. Neurodegeneration"},{"key":"32797_CR70","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-Amyloid Aggregates, Neurodegeneration, and neuron loss in Transgenic mice with five Familial alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"32797_CR71","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1038\/s41598-019-47287-1","volume":"9","author":"I Carreras","year":"2019","unstructured":"Carreras, I. et al. Dual dose-dependent effects of Fingolimod in a mouse model of alzheimer\u2019s disease. Sci. Rep. 9, 10972 (2019).","journal-title":"Sci. Rep."},{"key":"32797_CR72","doi-asserted-by":"crossref","first-page":"24939","DOI":"10.1038\/srep24939","volume":"6","author":"N Aytan","year":"2016","unstructured":"Aytan, N. et al. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of alzheimer\u2019s disease. Sci. Rep. 6, 24939 (2016).","journal-title":"Sci. Rep."},{"key":"32797_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1145\/1656274.1656278","volume":"11","author":"M Hall","year":"2009","unstructured":"Hall, M. et al. The WEKA data mining software: an update. SIGKDD Explor. Newsl. 11, 10\u201318 (2009).","journal-title":"SIGKDD Explor. Newsl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32797-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32797-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:05:38Z","timestamp":1769216738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32797-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32797"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32797-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7483320\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2919"}}